Glucohalal (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Glucose)

Glucohalal is formulated with electrolyte salts and glucose, which may be considered in clinical situations that require supplementation of these components.

• Oral electrolyte replacement in mild dehydration.
• Adjunctive glucose source for patients with low blood sugar under supervision.
• Supportive care during gastrointestinal losses.
• Temporary supplementation during fasting or pre‑operative preparation.

The safety profile of Glucohalal reflects the known effects of its individual ingredients.

Common

• Mild gastrointestinal discomfort such as nausea or bloating.
• Transient increase in urinary output.
• Slight alteration in taste perception.

Serious

• Hypernatremia or hyperkalemia in patients with impaired renal function.
• Severe electrolyte imbalance leading to cardiac arrhythmia.
• Allergic reaction including rash, itching, or swelling.

When considering Glucohalal, several precautionary measures should be observed to minimize risk.

• Assess renal and cardiac function before initiating therapy.
• Monitor serum electrolytes regularly during use.
• Avoid in individuals with known hypersensitivity to any component.
• Use with caution in patients taking diuretics or antihypertensive agents.
• Do not exceed the recommended volume without medical guidance.
• Keep the product out of reach of children.

Glucohalal may interact with other medications or substances that affect electrolyte balance or glucose metabolism.

Avoid

• Concurrent use with high‑dose potassium supplements.
• Combination with sodium‑rich intravenous fluids.
• Co‑administration with medications that prolong the QT interval.

Use with caution

• Diuretics that alter sodium or potassium levels.
• ACE inhibitors or ARBs that affect potassium homeostasis.
• Insulin or oral hypoglycemic agents due to added glucose.
• Antacids containing sodium bicarbonate.